Literature DB >> 3694130

Radioimmunoassay of 11 beta-hydroxyandrostenedione in laboratory diagnostics of selected endocrine disorders.

Z Putz1, R Hampl, J Velemínský, A Kreze, J Sulcová, L Stárka.   

Abstract

A specific radioimmunoassay of 11 beta-hydroxy-4-androstene-3,17-dione, an androgen of exclusively adrenal origin, is described and evaluated. The antiserum was raised in rabbits using 6 beta,11 beta-dihydroxy-4-androstene-3,17-dione-6 beta-hemisuccinate:bovine serumalbumin conjugate as an immunogen. The method has been used for determination of the plasma levels of the hormone in healthy subjects, including children, with regard to the possibility its use as a laboratory marker for monitoring corticoid therapy in patients with congenital adrenal hyperplasia and in patients with various endocrine disorders, under basal conditions and after dynamic tests. The plasma levels of 11 beta-hydroxyandrostenedione (means +/- s.d.) in healthy persons at 8 a.m. were 8.69 +/- 2.88 (men), 7.72 +/- 2.85 (women), 8.73 +/- 5.13 (boys) and 7.88 +/- 5.23 (girls) nmol/l, respectively. The hormone concentrations followed the pattern of circadian rhythm of cortisol, they were increased markedly after corticotropin and suppressed by dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694130     DOI: 10.1515/cclm.1987.25.10.723

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  3 in total

Review 1.  11-Keto-testosterone and other androgens of adrenal origin.

Authors:  L Stárka; M Dušková; J Vítků
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

2.  Effects of endogenous and exogenous hypercortisolemia on low-dose adrenocorticotropin test outcome in humans.

Authors:  J Kerlik; A Penesova; M Vlcek; R Imrich; L Starka; Z Radikova
Journal:  J Endocrinol Invest       Date:  2009-06-15       Impact factor: 4.256

3.  Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.

Authors:  R Hampl; L Foretová; J Sulcová; L Stárka
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.